PRESCRIBING · PART D · 2024
Total Rx claims
2,518
Beneficiaries
—
Total drug cost
$917K
Distinct drugs
29
Brand share
29.7%
Top prescribed drugs
Levetiracetam340 claims
Lamotrigine248 claims
Divalproex Sodium199 claims
Zonisamide190 claims
Felbamate170 claims
QUALITY · MIPS · 2024
Final MIPS score
86.7
Quality
67.0
Cost
73.1
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.49%
Group
CROSS-REFERENCE